ANTI-NEOPLASTIC DRUGS - CLINICAL PHARMACOLOGY AND THERAPEUTIC USE

被引：42

作者：

BENDER, RA ^{[1
]}

ZWELLING, LA ^{[1
]}

DOROSHOW, JH ^{[1
]}

LOCKER, GY ^{[1
]}

HANDE, KR ^{[1
]}

MURINSON, DS ^{[1
]}

COHEN, M ^{[1
]}

MYERS, CE ^{[1
]}

CHABNER, BA ^{[1
]}

机构：

[1] NCI, CLIN PHARMACOL BRANCH, BETHESDA, MD 20014 USA

来源：

DRUGS | 1978年 / 16卷 / 01期

关键词：

D O I：

10.2165/00003495-197816010-00003

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：46 / 87

页数：42

共 331 条

[1]

ADAMSON IYR, 1974, AM J PATHOL, V77, P185

[2]

ADAMSON RH, 1974, CANCER CHEMOTH REP 1, V58, P293

[3]

ALBERTS DS, 1976, CANCER RES, V36, P2790

[4]

ALBERTS DS, 1976, CANCER RES, V36, P2785

[5] COMPARISON OF HUMAN PHARMACOKINETICS OF VM-26 AND VP-16, 2 ANTINEOPLASTIC EPIPODOPHYLLOTOXIN GLUCOPYRANOSIDE DERIVATIVES [J].

ALLEN, LM ;

CREAVEN, PJ .

EUROPEAN JOURNAL OF CANCER, 1975, 11 (10) :697-707

[6]

AMBRE JJ, 1971, J LAB CLIN MED, V78, P343

[7]

[Anonymous], [No title captured]

[8]

ANSFIELD F, 1977, CANCER-AM CANCER SOC, V39, P34, DOI 10.1002/1097-0142(197701)39:1<34::AID-CNCR2820390107>3.0.CO

[9]

2-2

[10]

ARCAMONE F, 1976, CANCER TREAT REP, V60, P829

← 1 2 3 4 5 6 7 8 9 10 →